Market Position VivaChek specializes in in-vitro diagnostics and POCT with a broad portfolio including blood glucose, lipid testing, FIA, lateral flow rapid tests, and molecular diagnostics, indicating opportunities to cross-sell complementary biosensor and rapid test solutions to healthcare providers and labs.

Expansion Potential With a mid-size global footprint and a product line spanning diagnostics to biochemistry, there is potential to scale through international distributors and strategic partnerships, particularly in regions prioritizing rapid point-of-care testing and chronic disease monitoring.

Current Demand Recent product launches such as VivaDiag antigen tests point to strong demand for rapid diagnostics; sales opportunities may exist in diagnostic clinics, urgent care centers, and hospital wards seeking fast testing workflows.

Tech & Data Presence of digital tools like LinkedIn Insight Tag and Google Tag Manager suggests readiness for digital marketing and lead tracking; leverage data-driven campaigns and stakeholder targeting to optimize outreach to labs, clinics, and distributors.

Financials & Growth Revenue range and $14M funding indicate a company in growth mode with budget for expansion activities, enabling sales campaigns around multi-year procurement, government or private healthcare contracts, and bundled POCT solutions.